Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ANTI-THYMOCYTE GLOBULIN Cause Off label use? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Off label use have been filed in association with ANTI-THYMOCYTE GLOBULIN. This represents 9.3% of all adverse event reports for ANTI-THYMOCYTE GLOBULIN.

5
Reports of Off label use with ANTI-THYMOCYTE GLOBULIN
9.3%
of all ANTI-THYMOCYTE GLOBULIN reports
2
Deaths
0
Hospitalizations

How Dangerous Is Off label use From ANTI-THYMOCYTE GLOBULIN?

Of the 5 reports, 2 (40.0%) resulted in death.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ANTI-THYMOCYTE GLOBULIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ANTI-THYMOCYTE GLOBULIN Cause?

Pyrexia (7) Blood creatinine increased (5)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Related Pages

ANTI-THYMOCYTE GLOBULIN Full Profile All Off label use Reports All Drugs Causing Off label use ANTI-THYMOCYTE GLOBULIN Demographics